PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
Anticancer Research · 2023
DOI: 10.21873/anticanres.16300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Jungsup Byun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
- Department of Radiation Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
- Department of Surgery, Colorectal Cancer Center, School of Medicine, Kyungpook National University Chilgok Hospital, Kyungpook National University, Daegu, Republic of Korea.
- Department of Hematology/Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
- Department of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea; san_0729@naver.com.
Zitieren
APA
Byun, J., Park, N. J., Yoon, G., Kang, M. K., Kim, H. J., Park, S. Y., Park, J. S., Choi, G. S., Baek, J. H., Kim, J. G., & Seo, A. N. (2023). PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16300
Vancouver
Byun J, Park NJ, Yoon G, Kang MK, Kim HJ, Park SY, et al. PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Anticancer Research. 2023. doi:10.21873/anticanres.16300
BibTeX
@article{Byun2023,
author = {Byun, Jungsup and Park, Nora Jee-Young and Yoon, Ghilsuk and Kang, Min Kyu and Kim, Hye Jin and Park, Soo Yeun and Park, Jun Seok and Choi, Gyu Seog and Baek, Jin Ho and Kim, Jong Gwang and Seo, An Na},
title = {PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16300}
}
EUVIMED